» Articles » PMID: 32259300

Autoradiographic Mapping of Synaptic Vesicle Glycoprotein 2A in Non-human Primate and Human Brain

Overview
Journal Synapse
Specialty Neurology
Date 2020 Apr 8
PMID 32259300
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Synaptic vesicle glycoprotein 2A (SV2A) has been previously characterized as an imaging biomarker for assessment of synaptic density in positron emission tomography (PET) studies of patients with neurological conditions. To provide detailed maps of the brain localization of SV2A autoradiography studies were carried out using the SV2A radioligand [ C]UCB-J and whole hemisphere sections of non-human primate (NHP) and human brain. Binding of [ C]UCB-J was observed in all evaluated grey matter structures of the primate brain, with highest density in the caudate nucleus and cortex and lowest density in pons and globus pallidus. The density of [ C]UCB-J binding sites in human brain showed a good correlation with that in NHP brain. Binding of [ C]UCB-J in the white matter was very low relative to that in grey matter containing structures and was only inhibited to a minor extent by co-incubation with a saturating concentration of unlabelled UCB-J. The high-resolution images obtained in the present study may aid the interpretation of data acquired in human subjects examined using [ C]UCB-J in PET studies. In addition, observation of low binding for [ C]UCB-J in white matter (centrum semiovale) supports that this structure can be used as a reference region for quantitative analysis of [ C]UCB-J PET data.

Citing Articles

Assessing non-invasive quantitative methods for [F]SynVesT-1 PET imaging of synaptic vesicle glycoprotein 2A in the rat brain.

Berckmans L, Schrauwen C, Miranda A, Staelens S, Bertoglio D Eur J Nucl Med Mol Imaging. 2025; .

PMID: 40032689 DOI: 10.1007/s00259-025-07170-w.


Comprehensive mapping of synaptic vesicle protein 2A (SV2A) in health and neurodegenerative diseases: a comparative analysis with synaptophysin and ground truth for PET-imaging interpretation.

Bavarsad M, Spina S, Oehler A, Allen I, Suemoto C, Leite R Acta Neuropathol. 2024; 148(1):58.

PMID: 39476256 PMC: 11827533. DOI: 10.1007/s00401-024-02816-9.


SV2A PET shows hippocampal synaptic loss in cognitively unimpaired APOE ε4/ε4 homozygotes.

Snellman A, Tuisku J, Koivumaki M, Wahlroos S, Aarnio R, Rajander J Alzheimers Dement. 2024; 20(12):8802-8813.

PMID: 39475191 PMC: 11667521. DOI: 10.1002/alz.14327.


Acute transcutaneous auricular vagus nerve stimulation modulates presynaptic SV2A density in healthy rat brain: An in vivo microPET study.

Binda K, Real C, Simonsen M, Grove E, Bender D, Gjedde A Psychophysiology. 2024; 62(1):e14709.

PMID: 39428713 PMC: 11775880. DOI: 10.1111/psyp.14709.


Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression.

Asch R, Abdallah C, Carson R, Esterlis I Neuropsychopharmacology. 2024; 50(1):153-163.

PMID: 39039139 PMC: 11525584. DOI: 10.1038/s41386-024-01913-3.